We are live on ! Find out more
HAE icon

Haemonetics
HAE

181 hedge funds and large institutions have $2.22B invested in Haemonetics in 2017 Q1 according to their latest regulatory filings, with 15 funds opening new positions, 79 increasing their positions, 54 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more call options, than puts

Call options by funds: $9K | Put options by funds: $3K

46% more repeat investments, than reductions

Existing positions increased: 79 | Existing positions reduced: 54

5% more capital invested

Capital invested by funds: $2.11B → $2.22B (+$108M)

3.54% more ownership

Funds ownership: 101.53% → 105.07% (+3.5%)

8% less funds holding

Funds holding: 197 → 181 (-16)

33% less funds holding in top 10

Funds holding in top 10: 3 → 2 (-1)

38% less first-time investments, than exits

New positions opened: 15 | Existing positions closed: 24

Holders
181
Holders Change
-16
Holders Change %
-8.12%
% of All Funds
4.51%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.05%
New
15
Increased
79
Reduced
54
Closed
24
Calls
$9K
Puts
$3K
Net Calls
+$6K
Net Calls Change
+$492K

Top Buyers

1
BlackRock
BlackRock
New York
+$245M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$30.2M
3
CWAM
Columbia Wanger Asset Management
Illinois
+$22.9M
4
HM
HealthCor Management
New York
+$17.6M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$13M

Top Sellers

1
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$75.4M
2
BIM
Bogle Investment Management
Massachusetts
-$5.89M
3
CCMH
Cornerstone Capital Management Holdings
New York
-$5.82M
4
Fidelity Investments
Fidelity Investments
Massachusetts
-$5.56M
5
HA
Heartland Advisors
Wisconsin
-$4.05M
Name Holding Trade Value Shares
Change 		Change in
Stake
BlackRock
1
BlackRock
New York
$255M +$245M +6,276,880 +48,855%
Vanguard Group
2
Vanguard Group
Pennsylvania
$190M +$13M +332,087 +8%
Wellington Management Group
3
Wellington Management Group
Massachusetts
$170M +$30.2M +774,089 +23%
T. Rowe Price Associates
4
T. Rowe Price Associates
Maryland
$141M -$75.4M -1,931,040 -36%
Wells Fargo
5
Wells Fargo
California
$103M +$8.51M +217,836 +9%
Victory Capital Management
6
Victory Capital Management
Texas
$97.1M +$9.24M +236,481 +11%
Fuller & Thaler Asset Management
7
Fuller & Thaler Asset Management
California
$89.6M +$5.74M +146,911 +7%
Neuberger Berman Group
8
Neuberger Berman Group
New York
$81.5M +$7.2M +184,303 +10%
Dimensional Fund Advisors
9
Dimensional Fund Advisors
Texas
$68.9M +$702K +17,963 +1%
HM
10
HealthCor Management
New York
$64.9M +$17.6M +450,000 +39%
BCIM
11
Black Creek Investment Management
Ontario, Canada
$56.7M +$10.9M +277,870 +25%
State Street
12
State Street
Massachusetts
$51.4M +$3.81M +97,466 +8%
VBA
13
Van Berkom & Associates
Quebec, Canada
$46.4M +$220K +5,630 +0.5%
Franklin Resources
14
Franklin Resources
California
$40.6M – – –
PAM
15
Panagora Asset Management
Massachusetts
$34.5M +$10.6M +271,305 +47%
Renaissance Technologies
16
Renaissance Technologies
New York
$33.2M -$2.99M -76,600 -9%
HIM
17
Hermes Investment Management
United Kingdom
$31.2M +$378K +9,683 +1%
Bank of New York Mellon
18
Bank of New York Mellon
New York
$30.7M +$1.4M +35,852 +5%
Royal Bank of Canada
19
Royal Bank of Canada
Ontario, Canada
$28.2M +$2.16M +55,360 +9%
Northern Trust
20
Northern Trust
Illinois
$25.7M +$259K +6,621 +1%
Macquarie Group
21
Macquarie Group
Australia
$24.7M +$609K +15,593 +3%
CWAM
22
Columbia Wanger Asset Management
Illinois
$23.8M +$22.9M +586,290 New
Millennium Management
23
Millennium Management
New York
$23.6M +$5.85M +149,739 +35%
ACA
24
Anchor Capital Advisors
Massachusetts
$22.2M +$6.63M +169,850 +45%
Charles Schwab
25
Charles Schwab
California
$22.1M +$3.67M +93,948 +21%
1
2 3 4 5

HAE Hedge Fund Activity: Q1 2017 in Review

181 of the 4,017 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q1 2017, worth a combined $2.22B — up 5.1% from $2.11B a quarter earlier.

Sellers outnumbered buyers: 24 funds closed out of HAE and 15 opened new positions — a net loss of 9 holders — while 54 trimmed existing stakes and 79 added.

The largest buyer was BlackRock, adding an estimated $245M. The largest seller was T. Rowe Price Associates, cutting an estimated $75.4M.

  • 181 institutional investors held Haemonetics (HAE) as of Q1 2017, down from 197 in Q4 2016.
  • Funds reported $2.22B of Haemonetics stock for Q1 2017, up 5.1% quarter-over-quarter.
  • 15 funds opened new Haemonetics positions in Q1 2017 and 24 closed out, a net change of -9 holders.
  • The largest Haemonetics buyer in Q1 2017 was BlackRock, an estimated $245M added.
  • The largest Haemonetics seller in Q1 2017 was T. Rowe Price Associates, an estimated $75.4M sold.

Based on aggregated 13F filings for Q1 2017.